The ERICCIN trial is a single-centre , randomised double-blinded placebo-controlled trial which plans to recruit @ patients who are at risk of CIN , defined by pre-existent renal impairment ( estimated glomerular filtration rate < @ ml/min/@ @ m@ ) , over a period of @ years .